Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 10 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-10-2024-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 10, 2024, titled "Zydus receives final approval from USFDA for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases